Local pharmacy’s advice on surviving Loblaws buyout: Specialize!
Local pharmacies will need to specialize even further to stay alive after pharma giants merge, independent owners say
Writer & Business Reporter
Local pharmacies will need to specialize even further to stay alive after pharma giants merge, independent owners say
Next week’s National Pharmaceutical Congress will address problems in pharma marketing
Roche needs far more supplies this year than last of its flu treatment as number of cases nationally rises sharply
As Mississauga’s drug research companies prepare for possible new patent rules under the Canada-EU free trade deal, an industry group says improved intellectual property protection would be a shot in the arm for the city’s pivotal life sciences sector
Mississauga drug development company YM Biosciences announced today it had been acquired by Gilead Sciences Inc. for $465 million
Veterinary pharmaceutical company cuts ties with Mississauga testing lab Chemi Pharmaceutical Inc. after its licence was suspended by Health Canada
Mississauga-based drug developer Cipher Pharmaceuticals says its U.S. partner has begun selling and promoting a new drug to treat severe acne
Mississauga drug company Cipher Pharmaceuticals Inc. has received Health Canada approved for its new acne drug Epuris
Drug maker Roche Canada, which employs hundreds at its Mississauga pill-making plant, is getting Health Canada approval for a new test for an infectious virus common in organ transplants
Meadowvale’s “Pill Hill” is a cluster of most of the city’s biotechnology, biomedical and other life-science companies